Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Hans Sjögren

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Procedures

Chemicals & Drugs

Disorders

Anatomy

Physiology

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Liu Hua; Xue Zhong-tian; Sjögren Hans-Olov; Salford Leif G; Widegren Bengt
Low dose Zebularine treatment enhances immunogenicity of tumor cells.
Mårtensson Linda; Nilsson Rune; Ohlsson Tomas; Sjögren Hans-Olov; Strand Sven-Erik; Tennvall Jan
Improved tumor targeting and decreased normal tissue accumulation through extracorporeal affinity adsorption in a two-step pretargeting strategy.
Feridani Amir H Iranpour; Holmqvist Bo; Sjögren Hans-Olov; Strand Sven-Erik; Tennvall Jan; Baldetorp Bo
Combined flow cytometry and confocal laser scanning microscopy for evaluation of BR96 antibody cancer cell targeting and internalization.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Hans Sjögren (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2007: Liu Hua; Xue Zhong-tian; Sjögren Hans-Olov; Salford Leif G; Widegren Bengt
Low dose Zebularine treatment enhances immunogenicity of tumor cells.
Cancer letters 2007;257(1):107-15.
2007: Mårtensson Linda; Nilsson Rune; Ohlsson Tomas; Sjögren Hans-Olov; Strand Sven-Erik; Tennvall Jan
Improved tumor targeting and decreased normal tissue accumulation through extracorporeal affinity adsorption in a two-step pretargeting strategy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(18 Pt 2):5572s-5576s.
2007: Feridani Amir H Iranpour; Holmqvist Bo; Sjögren Hans-Olov; Strand Sven-Erik; Tennvall Jan; Baldetorp Bo
Combined flow cytometry and confocal laser scanning microscopy for evaluation of BR96 antibody cancer cell targeting and internalization.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2007;71(6):361-70.
2007: Mårtensson Linda; Nilsson Rune; Sjögren Hans-Olov; Strand Sven-Erik; Tennvall Jan
A nonsurgical technique for blood access in extracorporeal affinity adsorption of antibodies in rats.
Artificial organs 2007;31(4):312-6.
2007: Mårtensson Linda; Nilsson Rune; Ohlsson Tomas; Sjögren Hans-Olov; Strand Sven-Erik; Tennvall Jan
Reduced myelotoxicity with sustained tumor concentration of radioimmunoconjugates in rats after extracorporeal depletion.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(2):269-76.
2006: Badn Wiaam; Kalliomäki Suzanne; Widegren Bengt; Sjögren Hans Olov
Low-dose combretastatin A4 phosphate enhances the immune response of tumor hosts to experimental colon carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(15):4714-9.
2005: Wang Zhongmin; Mårtensson Linda; Nilsson Rune; Bendahl Pär-Ola; Lindgren Lars; Ohlsson Tomas; Sjögren Hans-Olov; Strand Sven-Erik; Tennvall Jan
Blood pharmacokinetics of various monoclonal antibodies labeled with a new trifunctional chelating reagent for simultaneous conjugation with 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid and biotin before radiolabeling.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(19 Pt 2):7171s-7177s.
2005: Mårtensson Linda; Wang Zhongmin; Nilsson Rune; Ohlsson Tomas; Senter Peter; Sjögren Hans-Olov; Strand Sven-Erik; Tennvall Jan
Determining maximal tolerable dose of the monoclonal antibody BR96 labeled with 90Y or 177Lu in rats: establishment of a syngeneic tumor model to evaluate means to improve radioimmunotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(19 Pt 2):7104s-7108s.
2003: Wang Zhongmin; Garkavij Michael; Ohlsson Tomas; Strand Sven-Erik; Sjögren Hans-Olov; Tennvall Jan
Biotinylation, pharmacokinetics, and extracorporeal adsorption of humanized MAb 111In-MN14 using an avidin-affinity column in rats.
Cancer biotherapy & radiopharmaceuticals 2003;18(3):365-75.
2003: Chen Shangwu; Anderson Per O; Li Li; Sjögren Hans-Olov; Wang Ping; Li Su-Ling
Functional association of cytokine-induced SH2 protein and protein kinase C in activated T cells.
International immunology 2003;15(3):403-9.
2002: Paulsson Kajsa M; Kleijmeer Monique J; Griffith Janice; Jevon Marc; Chen Shangwu; Anderson Per O; Sjogren Hans-Olov; Li Suling; Wang Ping
Association of tapasin and COPI provides a mechanism for the retrograde transport of major histocompatibility complex (MHC) class I molecules from the Golgi complex to the endoplasmic reticulum.
The Journal of biological chemistry 2002;277(21):18266-71.
2002: Wang Zhongmin; Garkavij Michael; Tennvall Jan G; Ohlsson Tomas; Strand Sven-Erik; Sjögren Hans-Olov
Application of extracorporeal immunoadsorption to reduce circulating blood radioactivity after intraperitoneal administration of indium-111-HMFG1-biotin.
Cancer 2002;94(4 Suppl):1287-92.
2002: Zelvyte Inga; Sjögren Hans-Olov; Janciauskiene Sabina
Effects of native and cleaved forms of alpha1-antitrypsin on ME 1477 tumor cell functional activity.
Cancer detection and prevention 2002;26(4):256-65.
2001: Hegardt P; Widegren B; Li L; Sjögren B; Kjellman C; Sur I; Sjögren H O
Nitric oxide synthase inhibitor and IL-18 enhance the anti-tumor immune response of rats carrying an intrahepatic colon carcinoma.
Cancer immunology, immunotherapy : CII 2001;50(9):491-501.
2001: Johansson A C; Visse E; Widegren B; Sjögren H O; Siesjö P
Computerized image analysis as a tool to quantify infiltrating leukocytes: a comparison between high- and low-magnification images.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2001;49(9):1073-79.
2001: Wang P; Anderson P O; Chen S; Paulsson K M; Sjögren H O; Li S
Inhibition of the transcription factors AP-1 and NF-kappaB in CD4 T cells by peroxisome proliferator-activated receptor gamma ligands.
International immunopharmacology 2001;1(4):803-12.
2001: Paulsson K M; Anderson P O; Chen S; Sjögren H O; Ljunggren H G; Wang P; Li S
Assembly of tapasin-associated MHC class I in the absence of the transporter associated with antigen processing (TAP).
International immunology 2001;13(1):23-9.
2000: Björkdahl O; Dohlsten M; Sjögren H O
Vaccination with B16 melanoma cells expressing a secreted form of interleukin-1beta induces tumor growth inhibition and an enhanced immunity against the wild-type B16 tumor.
Cancer gene therapy 2000;7(10):1365-74.
2000: Visse E; Johansson A C; Widegren B; Sjögren H O; Siesjö P
Immunohistochemical analysis of glioma-infiltrating leucocytes after peripheral therapeutic immunization with interferon-gamma-transfected glioma cells.
Cancer immunology, immunotherapy : CII 2000;49(3):142-51.
2000: Schiött A; Sjögren H O; Lindvall M
Association of decreased phosphorylation of ERK-2 with costimulation of rat T cell activation by MEK-1 inhibitors and TGF-beta1.
Immunology letters 2000;72(3):183-90.
2000: Kjellman C; Olofsson S P; Hansson O; Von Schantz T; Lindvall M; Nilsson I; Salford L G; Sjögren H O; Widegren B
Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma.
International journal of cancer. Journal international du cancer 2000;89(3):251-8.
2000: Hegardt P; Widegren B; Sjögren H O
Nitric-oxide-dependent systemic immunosuppression in animals with progressively growing malignant gliomas.
Cellular immunology 2000;200(2):116-27.
2000: Li S; Chen S; Xu X; Sundstedt A; Paulsson K M; Anderson P; Karlsson S; Sjögren H O; Wang P
Cytokine-induced Src homology 2 protein (CIS) promotes T cell receptor-mediated proliferation and prolongs survival of activated T cells.
The Journal of experimental medicine 2000;191(6):985-94.
2000: Li S; Paulsson K M; Chen S; Sjögren H O; Wang P
Tapasin is required for efficient peptide binding to transporter associated with antigen processing.
The Journal of biological chemistry 2000;275(3):1581-6.
2000: Schiött A; Johansson A C; Widegren B; Sjögren H O; Lindvall M
Effects of transforming growth factor beta1 expression in a rat colon carcinoma: growth inhibition, leukocyte infiltration and production of interleukin-10 and tumor necrosis factor alpha.
Cancer immunology, immunotherapy : CII 2000;48(10):579-87.
1999: Kjellman C; Sjögren H O; Salford L G; Widegren B
HERV-F (XA34) is a full-length human endogenous retrovirus expressed in placental and fetal tissues.
Gene 1999;239(1):99-107.
1999: Garkavij M; Tennvall J; Ohlsson T; Lindgren L; Hindorf C; Sjögren H O; Strand S E
Comparison of 125I- and (111)In-labeled monoclonal antibody BR96 for tumor targeting in combination with extracorporeal immunoadsorption.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3059s-3064s.
1999: Kjellman C; Sjögren H O; Widegren B
HERV-F, a new group of human endogenous retrovirus sequences.
The Journal of general virology 1999;80 ( Pt 9)():2383-92.
1999: Schiött A; Widegren B; Sjögren H O; Lindvall M
Transforming growth factor-beta1, a strong costimulator of rat T-cell activation promoting a shift towards a Th2-like cytokine profile.
Immunology letters 1999;67(2):131-9.
1999: Li S; Paulsson K M; Sjögren H O; Wang P
Peptide-bound major histocompatibility complex class I molecules associate with tapasin before dissociation from transporter associated with antigen processing.
The Journal of biological chemistry 1999;274(13):8649-54.
1999: Visse E; Siesjö P; Widegren B; Sjögren H O
Regression of intracerebral rat glioma isografts by therapeutic subcutaneous immunization with interferon-gamma, interleukin-7, or B7-1-transfected tumor cells.
Cancer gene therapy 1999;6(1):37-44.
1998: Schiött A; Sjögren H O; Lindvall M
The three isoforms of transforming growth factor-beta co-stimulate rat T cells and inhibit lymphocyte apoptosis.
Scandinavian journal of immunology 1998;48(4):371-8.
1997: Chen J Q; Strand S E; Tennvall J; Lindgren L; Hindorf C; Sjögren H O
Extracorporeal immunoadsorption compared to avidin chase: enhancement of tumor-to-normal tissue ratio for biotinylated rhenium-188-chimeric BR96.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(12):1934-9.
1997: Tennvall J; Garkavij M; Chen J; Sjögren H O; Strand S E
Improving tumor-to-normal-tissue ratios of antibodies by extracorporeal immunoadsorption based on the avidin-biotin concept: development of a new treatment strategy applied to monoclonal antibodies murine L6 and chimeric BR96.
Cancer 1997;80(12 Suppl):2411-8.
1997: Lindvall M; Eriksson H; Hedlund G; Sjögren H O
Selective cytotoxicity of two rodent T cell lymphomas to rat yolk sac tumours involves a retroviral envelope protein expressed by the lymphoma.
Scandinavian journal of immunology 1997;46(5):479-87.
1997: Sjögren H O; Isaksson M; Willner D; Hellström I; Hellström K E; Trail P A
Antitumor activity of carcinoma-reactive BR96-doxorubicin conjugate against human carcinomas in athymic mice and rats and syngeneic rat carcinomas in immunocompetent rats.
Cancer research 1997;57(20):4530-6.
1997: Sjögren H O
Therapeutic immunization against cancer antigens using genetically engineered cells.
Immunotechnology : an international journal of immunological engineering 1997;3(3):161-72.
1997: Li S; Sjögren H O; Hellman U; Pettersson R F; Wang P
Cloning and functional characterization of a subunit of the transporter associated with antigen processing.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(16):8708-13.
1997: Garkavij M; Tennvall J; Strand S E; Sjögren H O; JianQing C; Nilsson R; Isaksson M
Extracorporeal whole-blood immunoadsorption enhances radioimmunotargeting of iodine-125-labeled BR96-biotin monoclonal antibody.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(6):895-901.
1996: Siesjö P; Visse E; Sjögren H O
Cure of established, intracerebral rat gliomas induced by therapeutic immunizations with tumor cells and purified APC or adjuvant IFN-gamma treatment.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1996;19(5):334-45.
1996: Schiött A; Sjögren H O; Lindvall M
Monocyte-dependent costimulatory effect of TGF- beta 1 on rat T-cell activation.
Scandinavian journal of immunology 1996;44(3):252-60.
1996: Widegren B; Kjellman C; Aminoff S; Sahlford L G; Sjögren H O
The structure and phylogeny of a new family of human endogenous retroviruses.
The Journal of general virology 1996;77 ( Pt 8)():1631-41.
1996: Chen J; Strand S E; Sjögren H O
Optimization of radioiodination and biotinylation of monoclonal antibody chimeric BR96: an indirect labeling using N-succinimidyl-3-(tri-n-butylstannyl)benzoate conjugate.
Cancer biotherapy & radiopharmaceuticals 1996;11(3):217-26.
1996: Wingren A G; Björkdahl O; Labuda T; Björk L; Andersson U; Gullberg U; Hedlund G; Sjögren H O; Kalland T; Widegren B; Dohlsten M
Fusion of a signal sequence to the interleukin-1 beta gene directs the protein from cytoplasmic accumulation to extracellular release.
Cellular immunology 1996;169(2):226-37.
1996: Garkavij M; Tennvall J; Strand S E; Nilsson R; Lindgren L; Chen J; Isaksson M; Eriksson H; Sjögren H
Extracorporeal immunoadsorption from whole blood based on the avidin-biotin concept. Evaluation of a new method.
Acta oncologica (Stockholm, Sweden) 1996;35(3):309-12.
1995: Garkavij M; Tennvall J; Strand S E; Norrgren K; Lindgren L; Nilsson R; Sjögren H O
Enhanced radioimmunotargeting of 125I-labeled L6-biotin monoclonal antibody (MAb) by combining preload of cold L6 MAb and subsequent immunoadsorption in rats.
Cancer research 1995;55(23 Suppl):5874s-5880s.
1995: Siesjö P; Visse E; Sjögren H O
Increased proportion of CD8+ tumor responsive T cells after immunization with tum- versus tum+ rat glioma.
Cellular immunology 1995;165(2):225-33.
1995: Eriksson H; Sjögren H O
Inhibition of activation of human T lymphocytes by the complement C1 esterase inhibitor.
Immunology 1995;86(2):304-10.
1995: Labuda T; Lando P; Björkdahl O; Kalland T; Vessella R; Hedlund G; Eriksson H; Sjögren H O; Dohlsten M
A novel co-stimulatory T cell antigen co-expressed on renal cell carcinoma.
International immunology 1995;7(9):1425-32.
1995: Kjellman C; Sjögren H O; Widegren B
The Y chromosome: a graveyard for endogenous retroviruses.
Gene 1995;161(2):163-70.
1995: Parra E; Varga M; Sigvardsson M; Hedlund G; Kalland T; Leanderson T; Sjögren H O; Dohlsten M
Costimulation of human CD4+ T cells with LFA-3 and B7 induce distinct effects on AP-1 and NF-kappa B transcription factors.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(3):1132-40.
1995: Hedlund G; Hansson J; Ericsson P O; Sjögren H O; Dohlsten M
Expression of CD11a and CD45R isoforms defines distinct subsets of CD8+ TCR alpha beta and TCR gamma delta CTL in vivo.
Immunological reviews 1995;146():82-94.
1995: Hansson J; Dohlsten M; Sjögren H O; Hedlund G
Distinct splicing of CD45 mRNA in activated rat gamma delta cytotoxic T lymphocytes.
European journal of immunology 1995;25(1):75-9.
1995: Wingren A G; Parra E; Varga M; Kalland T; Sjögren H O; Hedlund G; Dohlsten M
T cell activation pathways: B7, LFA-3, and ICAM-1 shape unique T cell profiles.
Critical reviews in immunology 1995;15(3-4):235-53.
1994: Garkavij M; Tennvall J; Strand S E; Norrgren K; Nilsson R; Sjögren H O
Improving radioimmunotargeting of tumors: the impact of preloading unlabeled L6 monoclonal antibody on the biodistribution of 125I-L6 in rats.
Journal of nuclear biology and medicine (Turin, Italy : 1991) 1994;38(4):594-600.
1994: Hansson J; Ericsson P O; Widegren B; Dohlsten M; Sjögren H O; Hedlund G
Different types of in vivo induced cytolytic T lymphocytes are all LFA-Ihigh and lack CD45 exon 4 (CD45RA) but show distinct CD45RC profiles.
International immunology 1994;6(9):1375-81.
1994: Teneberg S; Jovall P A; Karlsson H; Sjögren H O; Brodin T
Isolation and characterization of a rat testis glycosphingolipid based on gangliotetraosylceramide and having a blood group B determinant extended with beta 3-linked N-acetylgalactosamine.
Journal of biochemistry 1994;116(3):697-703.
1994: Parra E; Wingren A G; Hedlund G; Björklund M; Sjögren H O; Kalland T; Sansom D; Dohlsten M
Costimulation of human CD4+ T lymphocytes with B7 and lymphocyte function-associated antigen-3 results in distinct cell activation profiles.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(6):2479-87.
1994: Bardi G; Aman P; Johansson B; Pandis N; Mandahl N; Bak-Jensen E; Björkman A; Sjögren H O; Andrén-Sandberg A; Mitelman F
Cytogenetic characterization of a periampullary adenocarcinoma of the pancreas, its liver metastasis, and a cell line established from the metastasis and a cell line established from the metastasis in a patient with Gardner's syndrome.
Cancer genetics and cytogenetics 1994;76(1):29-32.
1994: Strand S E; Norrgren K; Garkavij M; Lindgren L; Nilsson R; Sjogren H O; Tennvall J
A general extracorporeal immunoadsorption method to increase tumor-to-tissue ratio.
Cancer 1994;73(3 Suppl):1033-7.
1994: Lund-Pero M; Jeppson B; Arneklo-Nobin B; Sjögren H O; Holmgren K; Pero R W
Non-specific steroidal esterase activity and distribution in human and other mammalian tissues.
Clinica chimica acta; international journal of clinical chemistry 1994;224(1):9-20.
1993: Parra E; Wingren A G; Hedlund G; Sjögren H O; Kalland T; Sansom D; Dohlsten M
Human naive and memory T-helper cells display distinct adhesion properties to ICAM-1, LFA-3 and B7 molecules.
Scandinavian journal of immunology 1993;38(6):508-14.
1993: Wingren A G; Dahlenborg K; Björklund M; Hedlund G; Kalland T; Sjögren H O; Ljungdahl A; Olsson T; Ekre H P; Sansom D
Monocyte-regulated IFN-gamma production in human T cells involves CD2 signaling.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(3):1328-36.
1993: Siesjö P; Visse E; Lindvall M; Salford L; Sjögren H O
Immunization with mutagen-treated (tum-) cells causes rejection of nonimmunogenic rat glioma isografts.
Cancer immunology, immunotherapy : CII 1993;37(1):67-74.
1993: Ekman R; Servenius B; Castro M G; Lowry P J; Cederlund A S; Bergman O; Sjögren H O
Biosynthesis of corticotropin-releasing hormone in human T-lymphocytes.
Journal of neuroimmunology 1993;44(1):7-13.
1993: Norrgren K; Strand S E; Nilsson R; Lindgren L; Sjögren H O
A general, extracorporeal immunoadsorption method to increase the tumor-to-normal tissue ratio in radioimmunoimaging and radioimmunotherapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1993;34(3):448-54.
1993: Garkavij M; Tennvall J; Strand S E; Norrgren K; Nilsson R; Lindgren L; Sjögren H O
Improving radioimmonotargeting of tumors. Variation in the amount of L6 MAb administered, combined with an immunoadsorption system (ECIA).
Acta oncologica (Stockholm, Sweden) 1993;32(7-8):853-9.
1992: Hansson J; Ericsson P O; Dohlsten M; Sjögren H O; Kalland T; Hedlund G
Locally superantigen-activated peritoneal cytolytic T lymphocytes belong to the CD8+ CD45RC- subset and lyse MHC class II+ tumor cells.
Immunology letters 1992;34(3):229-36.
1992: Ericsson P O; Hansson J; Dohlsten M; Sjögren H O; Hiserodt J C; Hedlund G
In vivo induced allo-reactive natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1992;149(5):1504-9.
1992: Gjörloff A; Hedlund G; Kalland T; Sansom D; Fischer H; Trowsdale J; Sjögren H O; Dohlsten M
The LFA-3 adhesion pathway is differently utilized by superantigen-activated human CD4+ T-cell subsets.
Scandinavian journal of immunology 1992;36(2):243-50.
1992: Fischer H; Gjörloff A; Hedlund G; Hedman H; Lundgren E; Kalland T; Sjögren H O; Dohlsten M
Stimulation of human naive and memory T helper cells with bacterial superantigen. Naive CD4+45RA+ T cells require a costimulatory signal mediated through the LFA-1/ICAM-1 pathway.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(7):1993-8.
1991: Hedlund G; Dohlsten M; Herrmann T; Buell G; Lando P A; Segrén S; Schrimsher J; MacDonald H R; Sjögren H O; Kalland T
A recombinant C-terminal fragment of staphylococcal enterotoxin A binds to human MHC class II products but does not activate T cells.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(12):4082-5.
1991: Ericsson P O; Hansson J; Widegren B; Dohlsten M; Sjögren H O; Hedlund G
In vivo induction of gamma/delta T cells with highly potent and selective anti-tumor cytotoxicity.
European journal of immunology 1991;21(11):2797-802.
1991: Gjörloff A; Fischer H; Hedlund G; Hansson J; Kenney J S; Allison A C; Sjögren H O; Dohlsten M
Induction of interleukin-1 in human monocytes by the superantigen staphylococcal enterotoxin A requires the participation of T cells.
Cellular immunology 1991;137(1):61-71.
1991: Sjögren H O
Carriers in cancer treatment: monoclonal antibodies.
The European journal of surgery. Supplement. : = Acta chirurgica. Supplement 1991;(561):53-7.
1991: Ericsson P O; Lindén O; Dohlsten M; Sjögren H O; Hedlund G
Functions of rat CD4+ T cell subsets defined by CD45RB: CD45RB- cells have a much stronger response to recall antigens, whereas polyclonally activated cells of both subsets are equally efficient producers of IFN in the presence of exogenous IL-2.
Cellular immunology 1991;132(2):391-9.
1991: Wanying Q; Brodin T; Ceberg C; Ingvar C; Norrgren K; Sjögren H O; Strand S E
Radio-iodinated and internally labelled (35S) IgM monoclonal antibodies in a syngenic rat model.
Acta oncologica (Stockholm, Sweden) 1991;30(3):379-83.
1991: Ingvar C; Norrgren K; Strand S E; Brodin T; Jönsson P E; Sjögren H O
Tumour uptake of monoclonal antibody after regional intraarterial injection. Biokinetics in the nude rat heterotransplanted with malignant melanoma.
Acta oncologica (Stockholm, Sweden) 1991;30(1):65-9.
1991: Sjögren H O
T cell activation by superantigens--dependence on MHC class II molecules.
Current topics in microbiology and immunology 1991;174():39-51.
1991: Lindvall M; Sjögren H O
Inhibition of rat yolk sac tumour growth in vivo by a monoclonal antibody to the retroviral molecule P15E.
Cancer immunology, immunotherapy : CII 1991;33(1):21-7.
1990: Fischer H; Hedlund G; Kalland T; Sjögren H O; Dohlsten M
Independent regulation of IFN-gamma and tumor necrosis factor by IL-1 in human T helper cells.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(11):3767-72.
1990: Kristensson K; Dohlsten M; Fischer H; Ericsson P O; Hedlund G; Sjögren H O; Carlsson R
Phenotypical and functional differentiation of CD4+ CD45RA+ human T cells following polyclonal activation.
Scandinavian journal of immunology 1990;32(3):243-53.
1990: Schröder U; Pero R W; Sjögren H O
Magnetically tagged subsets of human lymphocytes for assays with laboratory robotics.
Clinical chemistry 1990;36(7):1282-7.
1990: Fischer H; Dohlsten M; Andersson U; Hedlund G; Ericsson P; Hansson J; Sjögren H O
Production of TNF-alpha and TNF-beta by staphylococcal enterotoxin A activated human T cells.
Journal of immunology (Baltimore, Md. : 1950) 1990;144(12):4663-9.
1990: Brodin N T; Jansson B; Sjögren H O
Rat monoclonal antibodies produced against rat colorectal adenocarcinomas define tumor- and colon-associated, auto-immunogenic antigens.
International journal of cancer. Journal international du cancer 1990;45(5):902-10.
1990: Thorén S A; Ankerst J; Sjögren H O
A microcalorimetric vessel for monitoring cytotoxic reactions in the micro-submicrowatt region.
Journal of biochemical and biophysical methods 1990;20(3):217-25.
1990: Ericsson P O; Hedlund G; Hansson J; Dohlsten M; Sjögren H O
Tumor-selective cytolysis is executed exclusively by CD45R+ CTL whereas allo-specific cytotoxicity can be executed also by CD45R- CTL.
Cellular immunology 1990;126(1):69-79.
1990: Lando P A; Dohlsten M; Kalland T; Sjögren H O; Carlsson R
The TcR-CD3 complex is required for activation of human lymphocytes with staphylococcal enterotoxin A.
Scandinavian journal of immunology 1990;31(2):133-8.
1990: Ingvar C; Norrgren K; Strand S E; Brodin T; Jönsson P E; Sjögren H O
Subcutaneous injection of monoclonal antibody 96.5. Biokinetics in the nude rat heterotransplanted with malignant melanoma.
Acta oncologica (Stockholm, Sweden) 1990;29(8):1047-53.
1989: Jansson B; Brodin T; Sjögren H O
Recognition of a high molecular weight glycoprotein (HMW-GP) associated with rat colon cancer cells by rat monoclonal antibodies.
Hybridoma 1989;8(5):493-505.
1989: Andersson U; Adolf G; Dohlsten M; Möller G; Sjögren H O
Characterization of individual tumor necrosis factor alpha-and beta-producing cells after polyclonal T cell activation.
Journal of immunological methods 1989;123(2):233-40.
1989: Ingvar C; Norrgren K; Strand S E; Brodin T; Jönsson P E; Sjögren H O
Biokinetics of radiolabeled monoclonal antibodies in heterotransplanted nude rats: evaluation of corrected specific tissue uptake.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1989;30(7):1224-34.
1989: Brodin N T; Jansson B; Hedlund G; Sjögren H O
Use of a monoclonal rat anti-mouse Ig light chain (RAMOL-1) antibody reduces background binding in immunohistochemical and fluorescent antibody analysis.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1989;37(7):1013-24.
1989: Ericsson P O; Hedlund G; Dohlsten M; Carlsson R; Sjögren H O
Gamma interferon induces the appearance of a CD4-, major histocompatibility complex class II+ macrophage subpopulation in the rat peritoneal cavity.
Scandinavian journal of immunology 1989;29(6):679-87.
1989: Fischer H; Dohlsten M; Lindvall M; Sjögren H O; Carlsson R
Binding of staphylococcal enterotoxin A to HLA-DR on B cell lines.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(9):3151-7.
1989: Thurin J; Brodin T; Bechtel B; Jovall P A; Karlsson H; Strömberg N; Teneberg S; Sjögren H O; Karlsson K A
Novel isoglobo-neolacto-series hybrid glycolipid detected by a monoclonal antibody is a rat colon tumor-associated antigen.
Biochimica et biophysica acta 1989;1002(3):267-72.
1989: Hedlund G; Dohlsten M; Ericsson P O; Sjögren H O
Rapid response to Con A by CD4+CD45R- rat memory lymphocytes as compared to CD4+CD45R+ lymphocytes.
Cellular immunology 1989;119(2):317-26.
1989: Hedlund G; Sandberg-Wollheim M; Sjögren H O
Increased proportion of CD4+CDw29+CD45R-UCHL-1+ lymphocytes in the cerebrospinal fluid of both multiple sclerosis patients and healthy individuals.
Cellular immunology 1989;118(2):406-12.
1989: Brodin N T; Thurin J; Karlsson K A; Mårtensson S; Sjögren H O
Monoclonal antibodies to glycolipids of the isoglobo-series detect tumor-associated antigens in rats.
International journal of cancer. Journal international du cancer 1989;43(2):317-26.
1989: Hedlund G; Dohlsten M; Sjögren H O; Carlsson R
Maximal interferon-gamma production and early synthesis of interleukin-2 by CD4+ CDw29- CD45R- p80- human T lymphocytes.
Immunology 1989;66(1):49-53.
1989: Dohlsten M; Hedlund G; Fischer H; Sjögren H O; Carlsson R
Proliferation of human CD4+45R+ and CD4+45R- T helper cells is promoted by both IL-2 and IL-4 while interferon-gamma production is restricted to IL-2 activated CD4+45R- T cells.
Immunology letters 1989;20(1):29-34.
1989: Jansson B; Brodin T; Sjögren H O
Rat serum antibodies binding to high-molecular-weight glycoprotein(s) on syngeneic colon carcinomas, demonstrated by competition with rat monoclonal antibody.
Cancer immunology, immunotherapy : CII 1989;30(2):105-12.
1988: Jansson B; Brodin T; Sjögren H O
A biotin-labelled antigen radioimmunoassay (BILA) for antibodies to membrane antigens useful for monoclonal antibody screening.
Journal of immunological methods 1988;115(2):219-26.
1988: Dohlsten M; Hedlund G; Sjögren H O; Carlsson R
Inhibitory effects of histamine on interleukin 2 and gamma interferon production of different human T helper cell subsets.
Scandinavian journal of immunology 1988;28(6):727-33.
1988: Dohlsten M; Hedlund G; Sjögren H O; Carlsson R
Two subsets of human CD4+ T helper cells differing in kinetics and capacities to produce interleukin 2 and interferon-gamma can be defined by the Leu-18 and UCHL1 monoclonal antibodies.
European journal of immunology 1988;18(8):1173-8.
1988: Brodin N T; Dahmén J; Nilsson B; Messeter L; Mårtensson S; Heldrup J; Sjögren H O; Lundblad A
Monoclonal antibodies produced by immunization with neoglycoproteins containing Gal alpha 1-4Gal beta 1-4Glc beta-O and Gal alpha 1-4Gal beta 1-4GlcNAc beta-O residues: useful immunochemical and cytochemical reagents for blood group P antigens and a differentiation marker in Burkitt lymphoma and other B-cell malignancies.
International journal of cancer. Journal international du cancer 1988;42(2):185-94.
1988: Dohlsten M; Kalland T; Sjögren H O; Carlsson R
Histamine inhibits interleukin 1 production by lipopolysaccharide-stimulated human peripheral blood monocytes.
Scandinavian journal of immunology 1988;27(5):527-32.
1988: Carlsson R; Fischer H; Sjögren H O
Binding of staphylococcal enterotoxin A to accessory cells is a requirement for its ability to activate human T cells.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(8):2484-8.
1988: Dohlsten M; Hedlund G; Bekassy A N; Lindén O; Garwicz S; Wiebe T; Sjögren H O; Carlsson R
Lymphocyte subpopulations and lymphokine production in children with constitutional aplastic anemia.
Pediatric hematology and oncology 1988;5(2):143-51.
1987: Dohlsten M; Sjögren H O; Carlsson R
Histamine acts directly on human T cells to inhibit interleukin-2 and interferon-gamma production.
Cellular immunology 1987;109(1):65-74.
1987: Lindén O; Dohlsten M; Boketoft A; Hedlund G; Sjögren H O
Catalase and lipopolysaccharide enhance proliferation in the rat mixed lymphocyte reaction.
Scandinavian journal of immunology 1987;26(3):223-8.
1987: Lindvall M L; Alumets J; Sjögren H O
Appearance of serum antibodies to rat yolk-sac carcinomas during the latent period prior to primary tumor development.
International journal of cancer. Journal international du cancer 1987;40(1):99-103.
1987: Lindvall M L; Brodin T; Sjögren H O
A rat monoclonal antibody 4D7 produced by a hybridoma established from a yolk-sac tumor-bearing rat binds selectively to the stage-specific embryonic antigen SSEA-1.
International journal of cancer. Journal international du cancer 1987;40(1):94-8.
1987: Hedlund G; Brodin T; Sjögren H O
Selective induction of OX19+ (CD5+) or OX19- (CD5-) alloreactive cytolytic lymphocytes in the rat.
Cellular immunology 1987;105(2):366-73.
1987: Carlsson R; Hedlund G; Sjögren H O
Abrogation of staphylococcal enterotoxin A-induced suppressor cell activity by the anti-Tac monoclonal antibody.
Scandinavian journal of immunology 1987;25(1):11-9.
1986: Schröder U; Segrén S; Gemmefors C; Hedlund G; Jansson B; Sjögren H O; Borrebaeck C A
Magnetic carbohydrate nanoparticles for affinity cell separation.
Journal of immunological methods 1986;93(1):45-53.
1986: Hedlund G; Segrén S; Jansson B; Sjögren H O
Evidence for the existence of W3/13+ monocytes in the rat.
Scandinavian journal of immunology 1986;24(4):387-92.
1986: Falk P; Holgersson J; Jovall P A; Karlsson K A; Strömberg N; Thurin J; Brodin T; Sjögren H O
An antigen present in rat adenocarcinoma and normal colon non-epithelial stroma is a novel Forssman-like glycolipid based on isoglobotetraosylceramide.
Biochimica et biophysica acta 1986;878(2):296-9.
1986: Dohlsten M; Sjögren H O; Carlsson R
Histamine inhibits interferon-gamma production via suppression of interleukin 2 synthesis.
Cellular immunology 1986;101(2):493-501.
1986: Brodin T; Thurin J; Strömberg N; Karlsson K A; Sjögren H O
Production of oligosaccharide-binding monoclonal antibodies of diverse specificities by immunization with purified tumor-associated glycolipids inserted into liposomes with lipid A.
European journal of immunology 1986;16(8):951-6.
1986: Dohlsten M; Lindén O; Hedlund G; Sjögren H O; Diamantstein T; Carlsson R
Synergistic action of gamma interferon and catalase to reverse the suppressive effect of peritoneal macrophages on concanavalin A-induced lymphocyte proliferation.
Scandinavian journal of immunology 1986;24(1):49-58.
1986: Hedlund G; Sjögren H O
The membrane phenotype of in vivo induced tumor selective cytolytic lymphocytes of the rat: a distinction from NK cells.
Cellular immunology 1986;100(1):232-8.
1986: Ankerst J; Sjögren H O; Fäldt R
Use of microcalorimetry in analysing the kinetics of ADCC.
Journal of immunological methods 1986;88(2):259-64.
1986: Brodin T; Olsson L; Sjögren H O
Feeder effect of enriched human monocytes on human hybridoma, myeloma, and lymphoma cell lines.
Methods in enzymology 1986;121():295-300.
1986: Dohlsten M; Carlsson R; Hedlund G; Sjögren H O; Bekassy A N; Garwicz S
Immunological abnormalities in a child with constitutional aplastic anemia.
Pediatric hematology and oncology 1986;3(1):89-96.
1985: Brodin T; Hellström I; Hellström K E; Karlsson K A; Sjögren H O; Strömberg N; Thurin J
Mouse monoclonal antibodies with specificity for the melanoma-associated ganglioside disialyllactosylceramide (GD3) also react with the structural analogue disialylparagloboside.
Biochimica et biophysica acta 1985;837(3):349-53.
1985: Carlsson R; Sjögren H O
Kinetics of IL-2 and interferon-gamma production, expression of IL-2 receptors, and cell proliferation in human mononuclear cells exposed to staphylococcal enterotoxin A.
Cellular immunology 1985;96(1):175-83.
1985: Carlsson R; Dohlsten M; Sjögren H O
Histamine modulates the production of interferon-gamma and interleukin-2 by mitogen-activated human mononuclear blood cells.
Cellular immunology 1985;96(1):104-12.
1985: Wallmark A; Ljung R; Nilsson I M; Holmberg L; Hedner U; Lindvall M; Sjögren H O
Polymorphism of normal factor IX detected by mouse monoclonal antibodies.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(11):3839-43.
1985: Eriksson H; Baldetorp B; Mattiasson B; Sjögren H O
A sensitive method to introduce membrane-bound proteins into recipient cells based on affinity enrichment of lipid vesicles to the recipient cell prior to fusion.
Biochimica et biophysica acta 1985;815(3):417-25.
1985: Flodgren P; Malmström P; Axelsson B; Boketoft A; Borgström S; Sjögren H O
Immune functions in melanoma patients during treatment with interferon [HuIFN-alpha (Le)] alone or in combination with cimetidine.
Anticancer research 1985;5(2):197-204.
1985: Ankerst J; Fäldt R; Sjögren H O
Microcalorimetry as a tool for the detection of complement-dependent cytotoxicity.
Journal of immunological methods 1985;77(2):267-74.
1985: Lamme S; Wallmark A; Holmberg L; Nilsson I M; Sjögren H O
The use of monoclonal antibodies in measuring factor VIII/von Willebrand factor.
Scandinavian journal of clinical and laboratory investigation 1985;45(1):17-26.
1985: Flodgren P; Hugander A; Sjögren H O
Recombinant leukocyte A interferon as single agent therapy or in combination with cimetidine in patients with advanced colo-rectal carcinoma. A phase II investigation.
Acta radiologica. Oncology 1985;24(1):25-34.
1985: Flodgren P; Sjögren H O
Influence in vitro on NK and K cell activities by cimetidine and indomethacin with and without simultaneous exposure to interferon.
Cancer immunology, immunotherapy : CII 1985;19(1):28-34.
1984: Eriksson H; Mattiasson B; Sjögren H O
Lectin-mediated binding of liposome-inserted membrane proteins to red blood cells. A method to detect binding of antibodies to purified rat histocompatibility antigen or binding of insulin to the insulin receptor.
Journal of immunological methods 1984;75(1):167-79.
1984: Hedlund G; Jansson B; Sjögren H O
Comparison of immune responses induced by rat RT-1 antigens presented as inserts into liposomes, as protein micelles and as intact cells.
Immunology 1984;53(1):69-78.
1984: Carlsson R; Dohlsten M; Boketoft A; Sjöquist J; Sjögren H O
Staphylococcal protein A (SpA) does not induce production of interferon-gamma in human mononuclear blood cells.
Cellular immunology 1984;86(1):136-44.
1984: Wallmark A; Grubb A; Freiburghaus C; Flodgren P; Husberg B; Lindholm T; Lindström C; Thysell H; Sjögren H O
Feasibility of extracorporeal on-line large-scale plasma adsorptions on protein A-sepharose columns in cancer patients.
Artificial organs 1984;8(1):72-81.
1984: Nilsson R; Sjögren H O
Antigen-independent binding of rat immunoglobulins in a radioimmunoassay. Solutions to an unusual background problem.
Journal of immunological methods 1984;66(1):17-25.
1984: Ankerst J; Fäldt R; Nilsson P G; Flodgren P; Sjögren H O
Complete remission in a patient with acute myelogenous leukemia treated with leukocyte alpha-interferon and cimetidine.
Cancer immunology, immunotherapy : CII 1984;17(1):69-71.
1983: Jansson B; Sjögren H O
Inhibition of antibody binding to viable cells by liposomes containing purified rat spleen glycoprotein.
Journal of immunological methods 1983;65(1-2):159-69.
1983: Flodgren P; Borgström S; Jönsson P E; Lindström C; Sjögren H O
Metastatic malignant melanoma: regression induced by combined treatment with interferon [HuIFN-alpha(Le)] and cimetidine.
International journal of cancer. Journal international du cancer 1983;32(6):657-65.
1983: Nilsson R; Myhre E; Kronvall G; Sjögren H O
Different protein A immunosorbents may have different binding specificity for rat immunoglobulins.
Journal of immunological methods 1983;62(2):241-5.
1983: Morizane T; Sjögren H O
Detection of different states of immunity to colon cancer in rats by a leukocyte adherence inhibition (LAI) assay assessing the adherence of T lymphocytes and monocytes selectively.
International journal of cancer. Journal international du cancer 1983;31(6):813-6.
1983: Morizane T; Sjögren H O
A leukocyte adherence inhibition (LAI) assay of anti-tumor immunity in rats using selective radioimmunological assessment of adherence of T lymphocytes and monocytes.
International journal of cancer. Journal international du cancer 1983;31(6):803-12.
1983: Brodin T; Olsson L; Sjögren H O
Cloning of human hybridoma, myeloma and lymphoma cell lines using enriched human monocytes as feeder layer.
Journal of immunological methods 1983;60(1-2):1-7.
1983: Sjögren H O; Nilsson K; Malmström P; Axelsson B
Column separation of monocytes by adherence to gelatin beads.
Journal of immunological methods 1983;56(3):285-94.
1982: Nilsson R; Brodin T; Sjögren H O
Quantitative analysis of rat Ig (sub) classes binding to cell surface antigens.
Journal of immunological methods 1982;55(2):179-91.
1982: Borgström S; von Eyben F E; Flodgren P; Axelsson B; Sjögren H O
Human leukocyte interferon and cimetidine for metastatic melanoma.
The New England journal of medicine 1982;307(17):1080-1.
1982: Ankerst J; Sjögren H O
Effect of selenium on the induction of breast fibroadenomas by adenovirus type 9 and 1,2-dimethylhydrazine-induced bowel carcinogenesis in rats.
International journal of cancer. Journal international du cancer 1982;29(6):707-10.
1982: Nilsson R; Myhre E; Kronvall G; Sjögren H O
Fractionation of rat IgG subclasses and screening for IgG Fc-binding to bacteria.
Molecular immunology 1982;19(1):119-26.
1982: Pero R W; Sjögren H O
The influence of monocyte (adherent cell) content in human mononuclear blood cell populations on the estimation of individual levels of N-acetoxy-2-acetylaminofluorene induced unscheduled DNA synthesis.
Carcinogenesis 1982;3(1):39-43.
1981: Malmström P; Jönsson A; Sjögren H O
ANAE staining pattern of rat lymphocytes: lack of correlation with lymphocyte subclasses.
Scandinavian journal of immunology 1981;14(5):523-7.
1981: Konrad P; Husberg B S; Sjögren H O
Enhanced growth of colon carcinoma isografts in rats concurrently receiving organ allografts.
Transplantation proceedings 1981;13(1 Pt 2):767-9.
1981: Axelsson B; Eriksson H; Borrebaeck C; Mattiasson B; Sjögren H O
Liposome immune assay (LIA). Use of membrane antigens inserted into labeled lipid vesicles as targets in immune assays.
Journal of immunological methods 1981;41(3):351-63.
1980: Malström P; Jönsson A; Sjögren H O
Countercurrent distribution of lymphocytes from human peripheral blood in an aqueous two-phase system. II. Separation into subsets of lymphocytes with distinctive functions.
Cellular immunology 1980;53(1):51-64.
1980: Hedlund G; Sjögren H O
Induction of transplantation immunity to rat colon carcinoma isografts by implantation of intact fetal colon tissue.
International journal of cancer. Journal international du cancer 1980;26(1):71-3.
1980: Malmström P; Jönsson A; Hallberg T; Sjögren H O
Countercurrent distribution of lymphocytes from human peripheral blood in an aqueous two-phase system. I. Separation into subsets of lymphocytes bearing distinctive markers.
Cellular immunology 1980;53(1):39-50.
1980: Sjögren H O
Immunoprevention of large bowel cancer: an animal model.
Cancer 1980;45(5 Suppl):1229-33.
1979: Bansal S C; Sjögren H O
Immunotherapy of tumor host.
The International journal of artificial organs 1979;2(3):116-8.
1979: Stigsson L; Ekelund L; Jonsson N; Sjögren H O
Transcatheter arterial embolization of experimental hepatic tumours in the rat.
Acta radiologica: diagnosis 1979;20(3):422-32.
1978: Nelson K; Malmström P; Jönsson A; Sjögren H O
Separation of rat leukocytes by countercurrent distribution in aqueous two-phase systems. II. Subpopulations which mediate selective and nonselective lysis of normal and colon carcinoma target cells in vitro.
Cellular immunology 1978;37(2):422-31.
1978: Malmström P; Nelson K; Jönsson A; Sjögren H O; Walter H; Albertsson P A
Separation of rat leukocytes by countercurrent distribution in aqueous two-phase systems. I. Characterization of subpopulations of cells.
Cellular immunology 1978;37(2):409-21.
1978: Riley V; Spackman D H; Santisteban G A; Dalldorf G; Hellstrom I; Hellstrom K E; Lance E M; Rowson K E; Mahy B W; Alexander P; Stock C C; Sjogren H O; Hollander V P; Horzinek M C
The LDH virus: an interfering biological contaminant.
Science (New York, N.Y.) 1978;200(4338):124-6.
1978: Nelson K; Sjögren H O
Effects of presensitization in vivo on cell-mediated responses to embryonic antigens in vitro.
International journal of cancer. Journal international du cancer 1978;21(1):108-14.
1977: Sjögren H O
Overview: the application of immunology to the development of immunotherapeutic programs for patients with large bowel cancer.
Cancer 1977;40(5 Suppl):2710-5.
1977: Ekelund L; Stigsson L; Jonsson N; Sjögren H O
Transcatheter arterial embolization of normal livers and experimental hepatic tumours in the rat.
Acta radiologica: diagnosis 1977;18(6):641-51.
1977: Lindell B; Aronsen K F; Rothman U; Sjögren H O
The circulation in liver tissue and experimental liver metastases before and after embolization of the liver artery.
Research in experimental medicine. Zeitschrift für die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie 1977;171(1):63-70.
1977: Nelson K A; Sjögren H O; Rosengren J E
Detection of antibodies to embryonic antigens in sera of multiparous or colon tumor-bearing rats by a new indirect immunofluorescence assay.
International journal of cancer. Journal international du cancer 1977;20(2):227-33.
1977: Steele G; Sjogren H O
Cell surface antigens in a rat colon cancer model: correlation with inhibition of tumor growth.
Surgery 1977;82(1):164-9.
1976: Sjögren H O
Immunological aspects of colorectal cancer.
Clinics in gastroenterology 1976;5(3):563-71.
1976: Ruoslahti E; Sjögren H O
Specific anti-fibroblast cytotoxicity of antibodies to fibroblast surface antigen.
International journal of cancer. Journal international du cancer 1976;18(3):375-8.
1976: Ekelund L; Göthlin J; Jonsson N; Sjögren H O
Pharmacoangiography in experimental tumours. Evaluation of vasoactive drugs.
Acta radiologica: diagnosis 1976;17(3):329-42.
1976: Steele G; Sjögren H O; Stadenberg I
In vitro cell-mediated immune reactions of melanoma and colorectal carcinoma patients demonstrated by long-term 51chromium assays.
International journal of cancer. Journal international du cancer 1976;17(1):27-39.
1975: Sjögren H O; Steele G
The immunology of large bowel carcinoma in a rat model.
Cancer 1975;36(6 Suppl):2469-71.
1975: Steele G; Sjögren H O
Enhanced growth of tumor isografts in rats after skin allografting.
Transplantation 1975;20(6):485-91.
1975: Steele G; Sjögren H O; Lannerstad O; Stadenberg I
A long-term 51chromium assay for in vitro cell-mediated tumor immunity. Correlation with simultaneously performed microplate assays.
International journal of cancer. Journal international du cancer 1975;16(4):682-93.
1975: Sjögren H O; Steele G
Colon carcinoma antigens in the rat.
Annals of the New York Academy of Sciences 1975;259():404-11.
1975: Steele G; Sjögren H O; Price M R
Tumor-associated and embryonic antigens in soluble fractions of a chemically-induced rat colon carcinoma.
International journal of cancer. Journal international du cancer 1975;16(1):33-51.
1975: Steele G; Sjögren H O; Rosengren J E; Lindström C; Larsson A; Leandoer L
Sequential studies of serum blocking activity in rats bearing chemically induced primary bowel tumors.
Journal of the National Cancer Institute 1975;54(4):959-67.
1975: Steele G; Ankerst J; Sjögren H O; Vang J; Lannerstad O
Absorption of blocking activity from human tumor-bearer sera by Staphylococcus aureus, Cowan I.
International journal of cancer. Journal international du cancer 1975;15(2):180-9.
1974: Steele G; Sjögren H O; Ankerst J
The effects of cyclophosphamide on in vitro correlates of tumor immunity.
International journal of cancer. Journal international du cancer 1974;14(6):743-52.
1974: Sjögren H O
Section meeting on immunology and immunotherapy.
The American journal of digestive diseases 1974;19(11):1064-7.
1974: Sjögren H O
Immunobiology of colon carcinomas.
The American journal of digestive diseases 1974;19(11):1033-5.
1974: Steele G; Sjogren H O
Embryonic antigens associated with chemically induced colon carcinomas in rats.
International journal of cancer. Journal international du cancer 1974;14(4):435-44.
1974: Steele G; Ankerst J; Sjögren H O
Immune responses of adenovirus type-9 infected (tumor-free) male rats against adenovirus type-9 induced mammary fibroadenomas and a chemically induced mammary carcinoma.
International journal of cancer. Journal international du cancer 1974;14(3):359-66.
1974: Ekelund L; Henrikson H; Olin T; Sjogren H O
Angiography in hepatic cysts and tumors in the rat.
Investigative radiology 1974;9(5):396-403.
1974: Ankerst J; Steele G; Sjögren H O
Cross-reacting tumor-associated antigen(s) of adenovirus type 9-induced fibroadenomas and a chemically induced mammary carcinoma in rats.
Cancer research 1974;34(8):1794-800.
1974: Steele G; Sjögren H O
Cross-reacting tumor-associated antigen (s) among chemically induced rat colon carcinomas.
Cancer research 1974;34(8):1801-7.
1974: Steele G; Ankerst J; Sjögren H O
Alteration of in vitro anti-tumor activity of tumor-bearer sera by absorption with Staphylococcus aureus, Cowan I.
International journal of cancer. Journal international du cancer 1974;14(1):83-92.
1974: Ankerst J; Jonsson N; Kjellén L; Norrby E; Sjögren H O
Induction of mammary fibroadenomas in rats by adenovirus type 9.
International journal of cancer. Journal international du cancer 1974;13(3):286-90.
1974: Sjögren H O
Effects on tumor growth in vivo by manipulation of the tumor immune response.
Johns Hopkins medical journal. Supplement 1974;3():51-60.
1973: Bansal S C; Sjögren H O
Regression of polyoma tumor metastasis by combined unblocking and BCG treatment--correlation with induced alterations in tumor immunity status.
International journal of cancer. Journal international du cancer 1973;12(1):179-93.
1973: Hellström I; Warner G A; Hellström K E; Sjögren H O
Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma.
International journal of cancer. Journal international du cancer 1973;11(2):280-92.
1973: Bansal S C; Hellström K E; Hellström I; Sjögren H O
Cell-mediated immunity and blocking serum activity to tolerated allografts in rats.
The Journal of experimental medicine 1973;137(3):590-602.
1973: Bansal S C; Sjögren H O
Correlation between changes in antitumor immune parameters and tumor growth in vivo in rats.
Federation proceedings 1973;32(2):165-72.
1973: Hellström I; Hellström K E; Sjögren H O; Warner G A
Destruction of cultivated melanoma cells by lymphocytes from healthy Black (North American Negro) donors.
International journal of cancer. Journal international du cancer 1973;11(1):116-22.
1973: Bansal S C; Sjögren H O
Effects of BCG on various facets of the immune response against polyoma tumors in rats.
International journal of cancer. Journal international du cancer 1973;11(1):162-71.
1972: Sjögren H O
[Modern cancer research--expected results for practical health care]
Läkartidningen 1972;69(52):6172-6.
1972: Bansal S C; Sjögren H O
In vitro testing of enhancement.
Transplantation proceedings 1972;4(4):509-12.
1972: Sjögren H O; Bansal S C
Relationship between blocking and unblocking activity and tumor growth in vivo.
National Cancer Institute monograph 1972;35():231-5.
1972: Sjögren H O
[New understanding of immunologic control mechanisms of tumor growth]
Schweizerische medizinische Wochenschrift 1972;102(33):1152-4.
1972: Bansal S C; Sjögren H O
Counteractions of the blocking of cell-mediated tumor immunity by inoculation of unblocking sera and splenectomy: immunotherapeutic effects on primary polyoma tumors in rats.
International journal of cancer. Journal international du cancer 1972;9(3):490-509.
1972: Sjögren H O; Hellström I; Bansal S C; Warner G A; Hellström K E
Elution of "blocking factors" from human tumors, capable of abrogating tumor-cell destruction by specifically immune lymphocytes.
International journal of cancer. Journal international du cancer 1972;9(2):274-83.
1972: Bansal S C; Hargreaves R; Sjögren H O
Facilitation of polyoma tumor growth in rats by blocking sera and tumor eluate.
International journal of cancer. Journal international du cancer 1972;9(1):97-108.
1971: Hellström I; Hellström K E; Sjögren H O; Warner G A
Serum factors in tumor-free patients cancelling the blocking of cell-mediated tumor immunity.
International journal of cancer. Journal international du cancer 1971;8(2):185-91.
1971: Bansal S C; Sjögren H O
"Unblocking" serum activity in vitro in the polyoma system may correlate with antitumour effects of antiserum in vivo.
Nature: New biology 1971;233(37):76-8.
1971: Sjögren H O; Hellström I; Bansal S C; Hellström K E
Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes.
Proceedings of the National Academy of Sciences of the United States of America 1971;68(6):1372-5.
1971: Sjögren H O; Borum K
Tumor-specific immunity in the course of primary polyoma and Rous tumor development in intact and immunosuppressed rats.
Cancer research 1971;31(6):890-900.
1971: Hellström I; Sjögren H O; Warner G; Hellström K E
Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms.
International journal of cancer. Journal international du cancer 1971;7(2):226-37.
1971: Hellström I; Hellström K E; Sjögren H O; Warner G A
Demonstration of cell-mediated immunity to human neoplasms of various histological types.
International journal of cancer. Journal international du cancer 1971;7(1):1-16.
1970: Sjögren H O; Jonsson N
Cellular immunity to Rous sarcoma in tumor-bearing chickens.
Cancer research 1970;30(9):2434-7.
1970: Ankerst J; Sjögren H O
Demonstration of two group-specific TSTAs in adenovirus-induced tumors.
International journal of cancer. Journal international du cancer 1970;6(1):84-94.
1970: Hellström I; Hellström K E; Sjögren H O
Serum mediated inhibition of cellular immunity to methylcholanthrene-induced murine sarcomas.
Cellular immunology 1970;1(1):18-30.
1970: Ankerst J; Sjögren H O
Cross-reacting tumor-specific transplantation of antigens in tumors induced by adenoviruses, 3, 14, and 12.
Cancer research 1970;30(5):1499-505.
1969: Ankerst J; Sjögren H O
Cross-reaction between TSTAs of tumors induced by adenoviruses of groups A and B.
Journal of general microbiology 1969;57(3):xxi.
1969: Ankerst J; Sjögren H O
Cross-reacting TSTAs in adeno 7 and 12 tumors demonstrated by 51Cr-cytotoxicity and isograft rejection tests.
International journal of cancer. Journal international du cancer 1969;4(3):279-87.
1969: Sjogren H O; Ankerst J
Cytotoxic antibodies against adeno tumors in rabbit anti-adenovirus immune sera.
Transplantation proceedings 1969;1(1):95-9.
1969: Sjögren H O; Ankerst J
Effect of BCG and allogeneic tumor cells on adenovirus type 12 tumorigenesis in mice.
Nature 1969;221(5183):863-4.
1969: Sjögren H O; Motet D
Separation of specific antibodies to TSTAs of adeno 12 and polyoma tumors.
International journal of cancer. Journal international du cancer 1969;4(1):14-20.
1967: Hellström I; Sjögren H O
In vitro demonstration of humoral and cell-bound immunity against common specific transplantation atigen(s) of adenovirus 12-induced mouse and hamster tumors.
The Journal of experimental medicine 1967;125(6):1105-18.
1967: Sjögren H O; Minowada J; Ankerst J
Specific transplantation antigens of mouse sarcomas induced by adenovirus type 12.
The Journal of experimental medicine 1967;125(4):689-701.
1967: Sjögren H O
Immunology of virus-induced tumours.
Modern trends in medical virology 1967;1(0):207-22.
1966: Sjögren H O
[Nobel Prize of the year. I. Peyton Rous]
Läkartidningen 1966;63(43):4098-101.
1966: Hellström I; Sjögren H O
Demonstration of common specific antigen(s) in mouse and hamster polyoma tumors.
International journal of cancer. Journal international du cancer 1966;1(5):481-9.
1966: Sjögren H O
[Cancer immunology]
Läkartidningen 1966;63(13):1247-56.
1966: Jonsson N; Sjögren H O
Specific transplantation immunity in relation to Rous sarcoma virus tumorigenesis in mice.
The Journal of experimental medicine 1966;123(3):487-503.
1966: Sjögren H O
Tumor specific antigens in viral neoplasms and in unrelated virus infected tumors.
Annales medicinae experimentalis et biologiae Fenniae 1966;44(2):227-31.
1965: Hellström I; Sjögren H O
Demonstration of H-2 isoantigens and polyoma specific tumor antigens by measuring colony formation in vitro.
Experimental cell research 1965;40(1):212-5.
1965: Sjögren H O; Hellström I
Induction of polyoma specific transplantation antigenicity in Moloney leukemia cells.
Experimental cell research 1965;40(1):208-12.
1965: Jonsson N; Sjögren H O
Isograft resistance to Rous sarcomas in mice inoculated with Rous chicken sarcoma when newborn.
Experimental cell research 1965;40(1):159-62.
1965: Sjögren H O
Transplantation methods as a tool for detection of tumor-specific antigens.
Progress in experimental tumor research. Fortschritte der experimentellen Tumorforschung. Progrès de la recherche expérimentale des tumeurs 1965;6():289-322.
1963: KLEIN G; SJOGREN H O; KLEIN E
Demonstration of host resistance against sarcomas induced by implantation of cellophane films in isologous (syngeneic) recipients.
Cancer research 1963;23():84-92.
1963: SJOGREN H O
Studies of the interaction between polyoma virus and its host animals.
Acta - Unio Internationalis Contra Cancrum 1963;19():330-1.
1962: KLEIN G; SJOGREN H O; KLEIN E
Demonstration of host resistance against isotransplantation of lymphomas induced by the Gross agent.
Cancer research 1962;22():955-61.
1962: SJOGREN H O; RINGERTZ N
Histopathology and transplantability of polyoma-induced tumors in strain A/Sn and three coisogenic resistant (IR) substrains.
Journal of the National Cancer Institute 1962;28():859-95.
1962: HELLSTROM K E; HELLSTROM I; SJOGREN H O
Karyologic studies on polyoma virus induced mouse tumors.
Experimental cell research 1962;26():434-7.
1962: HELLSTROM I; HELLSTROM K E; SJOGREN H O
Further studies on superinfection of polyoma-induced mouse tumors with polyoma virus in vitro.
Virology 1962;16():282-300.
1962: RINGERTZ N; SJOGREN H O
Polyoma-induced tumors in mice. Histology and transplantation characteristics.
Acta pathologica et microbiologica Scandinavica. Supplement 1962;Suppl 154():134-6.
1962: HELLSTROM K E; SJOGREN H O
Polyoma-induced tumors in mice. In vitro studies.
Acta pathologica et microbiologica Scandinavica. Supplementum 1962;154():137-8.
1961: SJOGREN H O
Further studies on the induced resistance against isotransplantation of polyoma tumors.
Virology 1961;15():214-9.
1960: KLEIN G; SJOGREN H O; KLEIN E; HELLSTROM K E
Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host.
Cancer research 1960;20():1561-72.
1960: KLEIN E; SJOGREN H O
Studies on the effect of isoantiserum on mouse sarcoma cells.
Transplantation bulletin 1960;26():442-6.
1960: HELLSTROM I; HELLSTROM K E; SJOGREN H O; KLEIN G
Superinfection of polyma-induced mouse tumors with polyoma virus in vitro.
Experimental cell research 1960;21():255-9.
1960: KLEIN E; SJOGREN H O
Humoral and cellular factors in homograft and isograft immunity against sarcoma cells.
Cancer research 1960;20():452-61.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Hans Sjögren

Research Profile (preview)

Living Beings

Procedures

Chemicals & Drugs

Disorders

Anatomy

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Hans Sjögren (preview)

All Publications